comparemela.com

Latest Breaking News On - Revance therapeutics - Page 7 : comparemela.com

Allergan Sues Revance for Confidentiality of Botox Trade Secrets

Allergan Sues Revance for Confidentiality of Botox Trade Secrets
natlawreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from natlawreview.com Daily Mail and Mail on Sunday newspapers.

Eli-richardson
Allergan
Revance-therapeutics
Judge-eli-richardson

Revance to Participate in Upcoming Investor Conferences

Revance Therapeutics, Inc. today announced that the company will be participating in the following investor conferences. Cowen 44th Annual Healthcare Conference Chief Executive Officer, Mark Foley.

Miami
Florida
United-states
Boston
Massachusetts
China
Mark-foley
Tobin-schilke
Linkedin
Revance-therapeutics-inc
Viatris-inc
Revance-therapeutics

Revance to Release Fourth Quarter and Full Year 2023 Financial Results on Wednesday February 28, 2024

Conference Call Scheduled for Wednesday, February 28, 2024 at 4:30 p.m. ET. .

China
Linkedin
Revance-therapeutics-inc
Viatris-inc
Revance-therapeutics
Shanghai-fosun-pharmaceutical
Resilient-hyaluronic-acid
Markets

Revance Therapeutics, Inc. (NASDAQ:RVNC) Shares Purchased by Innovis Asset Management LLC

Innovis Asset Management LLC lifted its stake in Revance Therapeutics, Inc. (NASDAQ:RVNC – Free Report) by 266.1% in the third quarter, HoldingsChannel reports. The firm owned 38,501 shares of the biopharmaceutical company’s stock after purchasing an additional 27,984 shares during the period. Innovis Asset Management LLC’s holdings in Revance Therapeutics were worth $442,000 at the […]

United-states
Piper-sandler
Goldman-sachs-group
Russell-investments-group-ltd
Innovis-asset-management
Principal-financial-group-inc
International-biotechnology-trust
Revance-therapeutics-company-profile
Needham-company
Barclays
Nasdaq
Revance-therapeutics-inc

Revance Therapeutics (NASDAQ:RVNC) Stock Price Up 12.5%

Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report) shares shot up 12.5% during mid-day trading on Tuesday . The company traded as high as $5.81 and last traded at $5.74. 615,845 shares changed hands during mid-day trading, a decline of 62% from the average session volume of 1,640,345 shares. The stock had previously closed at […]

United-states
Piper-sandler
Hermes-inc
Victory-capital-management-inc
Barclays
Nasdaq
Goldman-sachs-group
Jennison-associates
Revance-therapeutics-company-profile
Sargent-investment-group
Revance-therapeutics-inc
Revance-therapeutics

vimarsana © 2020. All Rights Reserved.